Pharmacy Times October 25, 2024

Ryan Nelson, PharmD, discusses the STRIPE Annual Meeting and Consensus Workshop’s focus on unifying pharmacogenetic guidelines across major organizations, such as the FDA, European Medicines Agency, Clinical Pharmacogenetics Implementation Consortium, and National Comprehensive Cancer Network.

Pharmacy Times interviewed Ryan Nelson, PharmD, medical director of precision medicine at ARUP Laboratories, on his participation in the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Annual Meeting and Consensus Workshop at US Pharmacopeia (USP) headquarters in Rockville, Maryland, where he led discussions on pharmacogenetic challenges in clinical practice. Nelson explained that a primary focus of the meeting was the need for aligned guidelines across major organizations, including FDA, European Medicines Agency (EMA), Clinical Pharmacogenetics Implementation Consortium (CPIC), and National Comprehensive Cancer Network (NCCN), particularly around...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Pharma, Pharma / Biotech, Trends
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025
Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers

Share This Article